Azithromycin treatment follow-up: antibacterial susceptibility of Chlamydia trachomatis in patients with chronic prostatitis

The antibacterial susceptibility of Chlamydia trachomatis in 138 patients with chronic prostatitis (CP) and clinical failures after antibacterial treatment with azithromycin (AZI) were investigated. Azithromycin was not found to be top-of-the-line drug in the follow-up treatment, showing only averag...

Full description

Saved in:
Bibliographic Details
Published in:International journal of antimicrobial agents 2004-03, Vol.23, p.79-82
Main Authors: Smelov, V., Krylova, T., Smelova, N., Norman, L.
Format: Article
Language:English
Subjects:
Anti-Bacterial Agents - therapeutic use
Azithromycin
Azithromycin - therapeutic use
Bacterial Infections - drug therapy
Chlamydia Infections - drug therapy
Chlamydia trachomatis
Chronic Disease
Chronic prostatitis
Humans
Male
Microbial Sensitivity Tests
Persistence
Prostatitis - complications
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The antibacterial susceptibility of Chlamydia trachomatis in 138 patients with chronic prostatitis (CP) and clinical failures after antibacterial treatment with azithromycin (AZI) were investigated. Azithromycin was not found to be top-of-the-line drug in the follow-up treatment, showing only average results in vitro. The investigation of the susceptibility of chlamydia to antibiotics in causes of chronic prostatitis is highly recommended.
ISSN:0924-8579
1872-7913
DOI:10.1016/j.ijantimicag.2003.09.001